# Effects of Intraoperative Hemoperfusion on Acute Kidney Injury After Aortic Dissection

Study · id `cardio:ct-nct05331495` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05331495](<https://clinicaltrials.gov/study/NCT05331495>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05331495

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 206 participants.

## Technical summary

Registry record NCT05331495. Randomized; no masking; primary purpose treatment. Start 2022-04-20 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 206 participants (planned count; ClinicalTrials.gov record NCT05331495, source copy `cardio:ctgov-nct05331495-2022-04-15`, retrieved 2026-11-18)
- Planned start: 2022-04-20 (anticipated) (ClinicalTrials.gov record NCT05331495, source copy `cardio:ctgov-nct05331495-2022-04-15`, retrieved 2026-11-18)
- Primary completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT05331495, source copy `cardio:ctgov-nct05331495-2022-04-15`, retrieved 2026-11-18)
- Completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT05331495, source copy `cardio:ctgov-nct05331495-2022-04-15`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT05331495, source copy `cardio:ctgov-nct05331495-2022-04-15`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05331495-2022-04-15`, retrieved 2026-11-18)

## The registry's words

- Brief title: Effects of Intraoperative Hemoperfusion on Acute Kidney Injury After Aortic Dissection
- Acronym: EIHPOAKIAD
- Condition: Aortic Dissection
- Intervention (Device): Intraoperative Hemoperfusion
- Lead sponsor: First Affiliated Hospital Xi'an Jiaotong University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic dissection (`cardio:aortic-dissection`)
- Registry lists this organization as the lead sponsor: First Affiliated Hospital Xi'an Jiaotong University (`cardio:org-first-affiliated-hospital-xi-an-jiaotong-university`)

## Provenance

Content hash: 933516eb76fdc6b9c6db9dd31ee4f1fe3e1a41a5d74f60a6f9348f8f22776603
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
